Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06573593Recruiting
JAK inhibitors for children with alopecia areata
This study looks at how well JAK inhibitor pills work for children with alopecia areata (a condition that causes hair loss). If you have tried one of these medicines for at least 3 months, your experience could help doctors learn more about the best treatments.
Hangzhou, ZhejiangAges 2–80 - NCT07761273Enrolling by invitation
Tricuspid valve repair using heart tissue
This study tests a new way to repair the tricuspid valve (the valve that controls blood flow on the right side of your heart) using a piece of your own heart tissue called the right atrial appendage. This might be an option for people who need this type of valve surgery.
Zagazig, Sharqia ProvinceAges 18–70 - NCT07764237RecruitingPhase 1
mRNA vaccine for older adults to prevent RSV and hMPV
This trial tests a new mRNA vaccine designed to protect older adults against two common respiratory viruses, RSV and hMPV. It aims to see if the vaccine is safe and creates a good immune response.
Québec, QuebecAges 60 years+ - NCT07764978RecruitingPhase 3
New drug combo for multiple myeloma without stem cell transplant
This trial tests a new drug called AZD0120 added to standard treatments for people newly diagnosed with multiple myeloma who are not eligible for a stem cell transplant. It aims to see if the combination can better control the disease and improve outcomes.
Gilbert, ArizonaAges 18 years+ - NCT07764328Recruiting
Supplement for hormone balance in women with PCOS
This trial tests a dietary supplement designed to improve hormone balance in women with PCOS or PCOS-like symptoms. It may help regulate menstrual cycles and reduce signs like acne or excess hair growth.
Los Angeles, CaliforniaAges 18–40 - NCT07759804RecruitingPhase 4
Switching from selexipag to inhaled treprostinil for pulmonary arterial hypertension
This study tests whether switching from the oral medicine selexipag to an inhaled medicine called treprostinil can improve symptoms or side effects in people with pulmonary arterial hypertension (PAH). It may be an option if you are not getting enough benefit or are having trouble tolerating selexipag.
Columbus, GeorgiaAges 18–80 - NCT07763652RecruitingPhase 1
Study of BL-ARC002 for advanced gastrointestinal and other solid tumors
This trial tests an investigational drug called BL-ARC002 for people with advanced or metastatic cancers of the esophagus, stomach, colon, rectum, or other solid tumors. The goal is to see if it is safe and effective in treating these cancers.
Guangzhou, GuangdongAges 18 years+ - NCT07760246RecruitingPhase 1
Heart safety study of verducatib in healthy adults
This study tests how different doses of the drug verducatib affect the heart in healthy adults. Participation helps ensure the drug is safe before it's studied in patients.
MannheimAges 18–50 - NCT07764185RecruitingPhase 2
Recharge and support program for dementia caregivers
This study tests an online program designed to help caregivers of people with Alzheimer's or other dementias recharge and reduce stress. It may help you feel more supported and better able to handle caregiving challenges.
Campbell, CaliforniaAges 18 years+ - NCT07758907Enrolling by invitation
Testing a device that reads fingerprints for drug screening
This trial tests a new drug screening system that reads fingerprints to detect drugs in the body. It will check if certain medications interfere with the device's accuracy, which may lead to faster and easier drug testing in the future.
Marlton, New JerseyAges 18–55 - NCT07766369RecruitingPhase 1
Drug interaction study for healthy adults
This trial tests how a new drug, E2086, interacts with other medicines in healthy volunteers. It helps make sure the drug is safe and works properly when combined with common medications.
Austin, TexasAges 18–55 - NCT07763015RecruitingPhase 2
Resmetirom for children with metabolic liver disease
This study tests a daily pill, resmetirom, to see if it can reduce fat and scarring in the livers of children and teens with MASH, a type of fatty liver disease. It may help improve liver health and prevent further damage.
Indianapolis, IndianaAges 6–17 - NCT07763639RecruitingPhase 1
Study of a new drug for advanced head and neck and other solid tumors
This trial tests an investigational drug, SI-B036, for people with advanced head and neck tumors or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and slow the disease.
Changsha, HunanAges 18–75 - NCT07759154RecruitingPhase 3
A study of centanafadine for adults with ADHD and emotional symptoms
This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.
Gainesville, FloridaAges 18–65 - NCT07761429RecruitingPhase 2/Phase 3
Study of a new drug with chemo for cancer of unknown primary
This trial tests a new drug (F520) combined with two chemotherapy drugs for people whose cancer started in an unknown place in the body. It aims to see if the combination shrinks tumors and is safe.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07764809Recruiting
Driving and facial skin moisture in Florida women
This study looks at skin hydration (how much water is in the skin) on the faces of women who drive a lot in Florida. It aims to see if the left side of the face (which gets more sun exposure while driving) is drier than the right.
Orlando, FloridaAges 25–65 - NCT07765498RecruitingPhase 1
Safety study of a new medicine in healthy volunteers
This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.
Dallas, TexasAges 18–65 - NCT07760363Recruiting
Foot exercise device for leg swelling
This study tests if using a foot pedal device while lying down can help reduce leg swelling in the hospital. It aims to see if this simple exercise can improve comfort and outcomes for people with fluid buildup.
Tulsa, OklahomaAges 18 years+ - NCT07765706RecruitingPhase 1
Testing an investigational medicine in healthy volunteers
This study tests a new medicine called INS1033 in healthy people to see if it is safe and how the body handles it. It is an early-stage study and does not involve treating any disease.
Salt Lake City, UtahAges 18–50 - NCT07758972RecruitingPhase 1
Gonorrhea vaccine safety study
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
Neu-Ulm, BavariaAges 18–50 - NCT07763197Recruiting
Sample collection for bladder cancer research
This study is collecting blood, urine, and tissue samples from people with high-risk non-muscle invasive bladder cancer to help develop better tests for tracking the disease. By participating, you might help improve future monitoring and treatment decisions.
Austin, TexasAges 18 years+ - NCT07766018RecruitingPhase 2
Elacestrant for advanced or metastatic breast cancer
This trial tests a new hormone therapy pill, elacestrant, for people with a specific type of breast cancer (ER+, HER2-) that has a certain genetic change (ESR1 mutation) and has grown despite previous hormone therapy. The goal is to see if this drug can help control the cancer.
ChibaAges 18 years+ - NCT07762287RecruitingPhase 1
How two forms of elinzanetant are processed in healthy women
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
Mount Royal, QuebecAges 18–65 - NCT07765446RecruitingPhase 2
Study of SIR2501 for nerve pain during chemotherapy
This trial tests whether SIR2501 can prevent or reduce nerve pain caused by paclitaxel chemotherapy. It is for people with solid tumors who are about to start paclitaxel treatment.
Hollywood, FloridaAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.